Company: DVAX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001029142-25-000117
Chunk: 211

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 211
---
4130,984$131 -$- $1,575,548 $(4,911)$(927,919)$642,849 Six Months Ended June 30, 2024         Balances at December 31, 2023129,530$130 -$— $1,554,634 $(2,108)$(930,584)$622,072 Issuance of common stock upon exercise of stock options294---2,054--2,054Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings1,0661--(8,576)--(8,575)Issuance of common stock under Employee Stock Purchase Plan94---904--904Stock compensation expense----26,532--26,532Total other comprehensive loss-----(2,803)-(2,803)Net income------2,6652,665Balances at June 30, 2024130,984$131 -$— $1,575,548 $(4,911)$(927,919)$642,849 

See accompanying notes.

7

Dynavax Technologies Corporation 

Condensed Consolidated Statements of Cash Flows 

(In thousands) 

(Unaudited) 

Six Months Ended June 30,20252024Operating activitiesNet (loss) income$(77,378)$2,665 Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    Depreciation and amortization2,415 2,259 Amortization of right-of-use assets1,660 1,668 Inventory write off3,976 1,264 Sublease termination loss (Note 5)- 4,765 Accretion of discounts on marketable securities(3,835)(8,465)Stock-based compensation expense27,434 26,532 Bad debt expense (Note 6)10,970 - Non-cash interest expense3,333 574 Loss on debt extinguishment82,095 - Changes in operating assets and liabilities:    Accounts and other receivables, net(26,439)(18,097)Inventories(9,609)(10,436)Prepaid expenses and other current assets(5,595)(6,391)Accounts payable(6,503)(569)Lease liabilities(2,152)(2,109)Accrued and other liabilities3,420